STOCK TITAN

Fulgent Genetics (NASDAQ: FLGT) CEO cancels 750,000-share prepaid forward

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4/A

Rhea-AI Filing Summary

Fulgent Genetics, Inc. director and CEO Ming Hsieh, through The Ming Hsieh Trust, unwound a prepaid variable forward arrangement involving 750,000 shares of common stock. The trust had previously entered this forward contract with an unaffiliated bank in August 2023.

On March 9, 2026, the Hsieh Trust elected to cancel the agreement for all 750,000 shares and paid an aggregate of $10,708,875 to the bank. After this payment and cancellation, those 750,000 shares held by the trust are no longer pledged to the bank.

Following the reported positions, Ming Hsieh holds 900,634 shares directly and has additional indirect holdings, including 7,895,115 and 220,816 shares held by trusts, plus smaller positions of 1,000 shares each in a minor’s account and by an immediate family member.

Positive

  • None.

Negative

  • None.
Insider Hsieh Ming, Ming Hsieh Trust
Role Chief Executive Officer | 10% Owner
Type Security Shares Price Value
Other Forward sale contract (obligation to sell) 750,000 $0.00 --
holding Common Stock -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Forward sale contract (obligation to sell) — 0 shares (Indirect, By Trust); Common Stock — 900,634 shares (Direct); Common Stock — 7,895,115 shares (Indirect, By Trust)
Footnotes (1)
  1. Securities held by The Ming Hsieh Trust (the "Hsieh Trust"). Mr. Hsieh is the trustee of the Hsieh Trust and possesses the sole voting and dispositive power with respect to securities held by the Hsieh Trust. Securities held by the Dynasty Trust. Mr. Hsieh is the grantor of the Dynasty Trust and he and his spouse, Eva Hsieh, and Jian Xie serve on the investment committee of the Dynasty Trust. Mr. Hsieh disclaims any beneficial interest except with respect to any pecuniary interest therein. Shares held in a Uniform Transfers to Minor Act account for which Ming Hsieh acts as custodian and possesses the sole voting and dispositive power. Shares, which were previously held in a Uniform Transfers to Minor Act account, now held by an immediate family member residing in the same household as Ming Hsieh. Previously, on August 21, 2023, the Hsieh Trust entered into a prepaid variable forward agreement (the "2023 Agreement") with an unaffiliated bank (the "Bank"). The 2023 Agreement obligated the Hsieh Trust to deliver up to 750,000 shares of the issuer's common stock, $0.0001 par value per share ("Common Stock") (or, at the Hsieh Trust's election, an equivalent amount of cash) to settle the 2023 Agreement. On March 9, 2026, the Hsieh Trust elected to cancel the 2023 Agreement with respect to all 750,000 shares. In connection with the cancellation, the Hsieh Trust paid an aggregate of $10,708,875 to the Bank. Following the payment and cancellation described above, the 750,000 shares held by the reporting person that were previously subject to the prepaid forward contract are no longer pledged to the Bank.
Forward contract shares 750,000 shares Shares subject to prepaid variable forward cancelled on March 9, 2026
Cancellation payment $10,708,875 Aggregate amount paid by Hsieh Trust to bank on cancellation
Direct holdings 900,634 shares Common stock directly held by Ming Hsieh after reported transactions
Trust holdings (Hsieh Trust) 7,895,115 shares Common stock held indirectly by trust with Ming Hsieh as trustee
Additional trust holdings 220,816 shares Common stock held indirectly by another trust associated with Ming Hsieh
UTMA account holdings 1,000 shares Common stock in Uniform Transfers to Minor Act account with Hsieh as custodian
Immediate family holdings 1,000 shares Common stock held by an immediate family member in same household
prepaid variable forward agreement financial
"Previously, on August 21, 2023, the Hsieh Trust entered into a prepaid variable forward agreement (the "2023 Agreement") with an unaffiliated bank"
Uniform Transfers to Minor Act account financial
"Shares held in a Uniform Transfers to Minor Act account for which Ming Hsieh acts as custodian"
dispositive power financial
"Mr. Hsieh is the trustee of the Hsieh Trust and possesses the sole voting and dispositive power with respect to securities held by the Hsieh Trust"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
beneficial interest financial
"Mr. Hsieh disclaims any beneficial interest except with respect to any pecuniary interest therein"
pecuniary interest financial
"Mr. Hsieh disclaims any beneficial interest except with respect to any pecuniary interest therein"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hsieh Ming

(Last)(First)(Middle)
C/O FULGENT GENETICS, INC.
4399 SANTA ANITA AVENUE

(Street)
EL MONTE CALIFORNIA 91731

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Fulgent Genetics, Inc. [ FLGT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
XForm filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)
03/11/2026
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock900,634D
Common Stock7,895,115IBy Trust(1)
Common Stock220,816IBy Trust(2)
Common Stock1,000IUniform Transfer to Minor Account(3)
Common Stock1,000IBy Immediate Family(4)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Forward sale contract (obligation to sell)(5)(6)03/09/2026J/K(5)(6)750,000(5) (5)(6) (5)(6)Common Stock750,000(5)(6)0IBy Trust(1)(5)(6)
1. Name and Address of Reporting Person*
Hsieh Ming

(Last)(First)(Middle)
C/O FULGENT GENETICS, INC.
4399 SANTA ANITA AVENUE

(Street)
EL MONTE CALIFORNIA 91731

(City)(State)(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer
XDirectorX10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
1. Name and Address of Reporting Person*
Ming Hsieh Trust

(Last)(First)(Middle)
C/O FULGENT GENETICS, INC.
4399 SANTA ANITA AVENUE

(Street)
EL MONTE CALIFORNIA 91731

(City)(State)(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
Explanation of Responses:
1. Securities held by The Ming Hsieh Trust (the "Hsieh Trust"). Mr. Hsieh is the trustee of the Hsieh Trust and possesses the sole voting and dispositive power with respect to securities held by the Hsieh Trust.
2. Securities held by the Dynasty Trust. Mr. Hsieh is the grantor of the Dynasty Trust and he and his spouse, Eva Hsieh, and Jian Xie serve on the investment committee of the Dynasty Trust. Mr. Hsieh disclaims any beneficial interest except with respect to any pecuniary interest therein.
3. Shares held in a Uniform Transfers to Minor Act account for which Ming Hsieh acts as custodian and possesses the sole voting and dispositive power.
4. Shares, which were previously held in a Uniform Transfers to Minor Act account, now held by an immediate family member residing in the same household as Ming Hsieh.
5. Previously, on August 21, 2023, the Hsieh Trust entered into a prepaid variable forward agreement (the "2023 Agreement") with an unaffiliated bank (the "Bank"). The 2023 Agreement obligated the Hsieh Trust to deliver up to 750,000 shares of the issuer's common stock, $0.0001 par value per share ("Common Stock") (or, at the Hsieh Trust's election, an equivalent amount of cash) to settle the 2023 Agreement.
6. On March 9, 2026, the Hsieh Trust elected to cancel the 2023 Agreement with respect to all 750,000 shares. In connection with the cancellation, the Hsieh Trust paid an aggregate of $10,708,875 to the Bank. Following the payment and cancellation described above, the 750,000 shares held by the reporting person that were previously subject to the prepaid forward contract are no longer pledged to the Bank.
Remarks:
This Form 4/A amends the Form 4 filed on March 11, 2026, solely to add The Ming Hsieh Trust as an additional Reporting Person because EDGAR access for the Ming Hsieh Trust was not available at the time of the filing of the Original Form 4. No other changes have been made to the Original Form 4, and no additional transactions are being reported.
/s/ Paul Kim as Attorney-in-Fact03/31/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did FLGT CEO Ming Hsieh change in his forward contract on March 9, 2026?

Ming Hsieh’s trust cancelled a prepaid variable forward covering 750,000 Fulgent Genetics shares. The trust paid $10,708,875 to the bank, and those shares, previously pledged under the contract, are now fully unencumbered and remain held by the trust.

How many Fulgent Genetics (FLGT) shares were covered by the cancelled forward contract?

The cancelled prepaid variable forward agreement covered 750,000 shares of Fulgent Genetics common stock. After the cancellation and related cash payment, these 750,000 shares continue to be held by the trust but are no longer pledged as collateral to the bank.

How much did the Ming Hsieh Trust pay to cancel the FLGT forward agreement?

To cancel the prepaid variable forward agreement, the Ming Hsieh Trust paid the unaffiliated bank an aggregate of $10,708,875. Following this payment, the 750,000 Fulgent Genetics shares subject to the contract were released from their prior pledge to the bank.

What are Ming Hsieh’s direct share holdings in Fulgent Genetics (FLGT) after this Form 4/A?

After the reported transactions, Ming Hsieh directly holds 900,634 shares of Fulgent Genetics common stock. This direct position is separate from his substantial indirect holdings through trusts, a Uniform Transfers to Minor Act account, and an immediate family member’s account.

What indirect FLGT holdings are reported for trusts associated with Ming Hsieh?

Indirectly, filings show 7,895,115 and 220,816 Fulgent Genetics shares held by trusts associated with Ming Hsieh. He serves as trustee or on an investment committee, with stated voting or investment powers and specific beneficial interest disclaimers described in the accompanying footnotes.

How are Fulgent Genetics (FLGT) shares held for Ming Hsieh’s family reported?

The filing reports 1,000 FLGT shares in a Uniform Transfers to Minor Act account, where Ming Hsieh is custodian, and 1,000 shares held by an immediate family member in the same household. These are classified as indirect holdings with specified voting or custodial roles.